The OncoSim-Breast Cancer Microsimulation Model
Authors:
- Jean H. E. YongJYJean H. E. Yong
- Claude NadeauCNClaude Nadeau
- William M. FlanaganWFWilliam M. Flanagan
- Andrew J. ColdmanACAndrew J. Coldman
- Keiko AsakawaKAKeiko Asakawa
- Rochelle GarnerRGRochelle Garner
- Natalie FitzgeraldNFNatalie Fitzgerald
- Martin J. YaffeMYMartin J. Yaffe
- Anthony B. MillerAMAnthony B. Miller
Open Access
- 3 March 2022
- journal article
- research article
- Published by MDPI AG in Current Oncology
- Vol. 29 (3) , 1619-1633
Abstract
Background: OncoSim-Breast is a Canadian breast cancer simulation model to evaluate breast cancer interventions. This paper aims to describe the OncoSim-Breast model and how well it reproduces observed breast cancer trends. Methods: The OncoSim-Breast model simulates the onset, growth, and spread of invasive and ductal carcinoma in situ tumours. It combines Canadian cancer incidence, mortality, screening program, and cost data to project population-level outcomes. Users can change the model input to answer specific questions. Here, we compared its projections with observed data. First, we compared the model’s projected breast cancer trends with the observed data in the Canadian Cancer Registry and from Vital Statistics. Next, we replicated a screening trial to compare the model’s projections with the trial’s observed screening effects. Results: OncoSim-Breast’s projected incidence, mortality, and stage distribution of breast cancer were close to the observed data in the Canadian Cancer Registry and from Vital Statistics. OncoSim-Breast also reproduced the breast cancer screening effects observed in the UK Age trial. Conclusions: OncoSim-Breast’s ability to reproduce the observed population-level breast cancer trends and the screening effects in a randomized trial increases the confidence of using its results to inform policy decisions related to early detection of breast cancer.Keywords
All Related Versions
This publication has 41 references indexed in Scilit:
- Breast Cancer After Use of Estrogen Plus Progestin and Estrogen AloneJAMA Oncology, 2015
- Eligibility for low-dose computerized tomography screening among asbestos-exposed individualsScandinavian Journal of Work, Environment & Health, 2015
- Using the Cancer Risk Management Model to Evaluate Colorectal Cancer Screening Options for CanadaCurrent Oncology, 2015
- Is carcinoma in situ a precursor lesion of invasive breast cancer?International Journal of Cancer, 2014
- Ten-Year Risk of Diagnostic Mammograms and Invasive Breast Procedures After Breast-Conserving Surgery for DCISJNCI: Journal of the National Cancer Institute, 2012
- Pathology of Breast and Ovarian Cancers among BRCA1 and BRCA2 Mutation Carriers: Results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA)Cancer Epidemiology, Biomarkers & Prevention, 2012
- Increasing Rates of Contralateral Prophylactic Mastectomy Among Patients With Ductal Carcinoma In SituJournal of Clinical Oncology, 2009
- Breast tumours following combined hormone replacement therapy express favourable prognostic factorsInternational Journal of Cancer, 2007
- Effect of mammographic screening from age 40 years on breast cancer mortality at 10 years' follow-up: a randomised controlled trialThe Lancet, 2006
- Rating the Risk Factors for Breast CancerAnnals of Surgery, 2003